NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Results of Two New Studies at the American Diabetes Association’s 80th Scientific Sessions
DarioHealth (NASDAQ: DRIO), a leading global digital therapeutics (“DTx”) company, today presented the results of two new studies at the American Diabetes Association's (ADA) 80th Scientific Sessions that showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. "These exciting and positive results further validate the use of quality digital engagement in enhancing patient understand and management of chronic diseases,” Rick Anderson, president and general manager North America of DarioHealth, said in the news release. “Hypertension is a major contributor to cardiovascular disease, representing approximately 10% of all global health…







